advpub_c15-00055

17
Chemical and Pharmaceutical Bulletin Advance Publication by J-STAGE DOI:10.1248/cpb.c15-00055 2015 The Pharmaceutical Society of Japan Advance Publication March 12, 2015 Chem. Pharm. Bull. Note Catunaroside I-L, Four New Triterpenoid Saponins from the Stem Bark of Catunaregam Spinosa Jun Li, b Xuan Huang, a Xiao-Hong Jiang, a Qi-Feng Zhu, a Yun Yang, a and Guang-Chun Gao * ,a a Key Laboratory of Natural Medicine and Health Food R & D Technology, College of Medicine, Jiaxing University; NO.118, JiaHang Road, Jiaxing 314001, P. R. China: b Jiaxing Academy of Agricultural Sciences;ShuangQiao Road, Jiaxing 314016, P. R. China. * To whom correspondence should be addressed. E-mail: [email protected]

Transcript of advpub_c15-00055

  • Chemical and Pharmaceutical Bulletin Advance Publication by J-STAGE DOI:10.1248/cpb.c15-00055

    2015 The Pharmaceutical Society of Japan

    Advance Publication

    March 12, 2015

    Chem. Pharm. Bull.

    Note

    Catunaroside I-L, Four New Triterpenoid Saponins from the Stem Bark of

    Catunaregam Spinosa

    Jun Li,b Xuan Huang,

    a Xiao-Hong Jiang,

    a Qi-Feng Zhu,

    a Yun Yang,

    a and

    Guang-Chun Gao *

    ,a

    a Key Laboratory of Natural Medicine and Health Food R & D Technology, College of

    Medicine, Jiaxing University; NO.118, JiaHang Road, Jiaxing 314001, P. R. China: b Jiaxing

    Academy of Agricultural Sciences;ShuangQiao Road, Jiaxing 314016, P. R. China.

    * To whom correspondence should be addressed. E-mail: [email protected]

  • Chemical and Pharmaceutical Bulletin Advance Publication

    Abstracts: Four new triterpenoid saponins, Catunaroside I

    [3-O--D-glucopyranosyl-(13)--D-glucopyranosyl-arjunic acid

    28-O--D-glucopyranoside] (1), Catunaroside J

    [3-O--D-glucopyranosyl-(12)-[-D-glucopyranosyl-(13)]--D -glucopyranosyl-arjunic

    acid 28-O--D-glucopyranoside] (2), Catunaroside K

    [3-O--D-glucopyranosyl-(12)-[-D-glucopyranosyl-(13)]--D-glucopyranosyl-tormenti

    c acid] (3), and Catunaroside L

    [3-O--D-glucopyranosyl-(12)-[-D-glucopyranosyl-(13)]--D-glucopyranosyl-pomolic

    acid] (4), and two known triterpenoid saponin Arjunetoside (5) and RandiasaponinVII (6),

    were isolated from the stem bark of Catunaregam spinosa. Their structures were elucidated

    on the basis of their spectral data and chemical evidence.

    Key words: Catunaroside I-L, triterpenoid saponin, Catunaregam spinosa, Rubiaceae.

  • Chemical and Pharmaceutical Bulletin Advance Publication

    Catunaregam spinosa T. (Rubiaceae), distributed in tropical and semitropical areas, was

    known as a folk medicine in India and Brazil for its antispasmodic, antidysenteric,

    anti-inflammatory, immunomodulatory and antifertility properties.1-4)

    Many phytochemical

    research has been done on this plant, and coumarin glucosides,5)

    iridoid glucosides, 1)

    and

    triterpenoid saponins4, 6, 7)

    were found. Our previous investigations on this plant had led to the

    isolation of iridioid,8)

    norneolignans,9)

    triterpenoid saponins.10, 11)

    In continuation of our

    studies on the plants, four new triterpenoid saponins, Catunaroside I-L, together with

    Arjunetoside and RandiasaponinVII, were isolated from the n-BuOH extract of its stem bark

    by preparative HPLC. The isolation and structure determination of those triterpenoid saponins

    were elucidated in this paper.

    Results and Discussion

    Compound 1 was obtained as a colorless amorphous powder. The molecular formula

    C48H78O20 was determined by a combination of NMR spectra and HR-ESI-MS which

    exhibited a molecular ion peak at m/z: 997.4980 [M + Na] + (Calcd for C48H78O20Na:

    977.4984). On acid hydrolysis, 1 afforded only glucose as sugar moiety that was identical to

    an authentic sample by Silica gel TLC. The IR spectrum showed absorption bands at 3417

    cm 1

    (OH), 1726 cm 1

    (C = O), 1643 cm 1

    (C = C). The 13

    C-NMR spectrum exhibited 48

    signals, of which 30 were assigned to the aglycone moiety and 18 to the sugars. In the

    1H-NMR spectrum, seven methyl protons ( 1.37, 1.05, 0.96, 1.14, 1.63, 1.14 and 0.98 ppm;

    each 3H, s), one olefinic methine proton ( 5.49, br s), and three anomeric protons ( 4.91, d,

    8.0 Hz; 5.29, d, 7.5Hz; 6.38, d, 8.0 Hz) were observed. The 13

    C-NMR spectrum also showed

  • Chemical and Pharmaceutical Bulletin Advance Publication

    seven methyl carbons at 28.4, 18.0, 16.6, 17.6, 24.9, 28.7 and 24.6 ppm, two olefinic

    carbons at 122.9 and 144.3 ppm, three oxygenated methine carbons at 66.6, 95.7 and 81.0

    ppm, and three anomeric carbons at 106.0, 105.9 and 95.9. Based on the above data, it was

    deduced that 1 was an olean-12-ene type triterpenoid glycoside with three units of glucose.

    The comparison of 1H- and

    13C-NMR spectrum data of aglycone part of 1 with that of arjunic

    acid 12)

    indicated that compound 1 possessed a 2, 3, 19-trihydroxyolean-12-ene-28-oic

    acidic aglycone. The chemical shifts of C-3 ( 95.7) and C-28 ( 177.2) 13) implied that 1 was

    a 3, 28-bisdesmosidic glycoside. This hypothesis was also in agreement with the relatively

    downfield shifts of anomeric protons ( 4.91, 6.38 ppm) and the corresponding upfield shifts

    of anomeric carbons ( 106.0, 95.9 ppm). In the HMBC spectrum, significant correlations

    between signals at 4.91(H-1) and 95.7 (C-3), 5.29 (H-1) and 88.9 (C-3), and 6.37

    (H-1) and 177.2 (C-28) were observed. The -anomeric configurations of glucose units

    were determined by the relatively large 3JH1, H2 coupling constants (7.5-8.0 Hz). Considering

    above information compound 1 was elucidated as

    3-O--D-glucopyranosyl-(13)--D-glucopyranosyl-arjunic acid

    28-O--D-glucopyranoside.

    Compound 2, a colorless amorphous powder, was analyzed to have the molecular formula

    of C54H88O25 by its HR-ESI-MS spectrum (m/z: 1159.5563 [M + Na] +). Acid hydrolysis of 2

    afforded glucose as the only sugar unit. The 13

    C-NMR spectrum revealed 54 signals, of which

    30 were assigned to the aglycone and 24 to the sugars. The 1H-NMR spectrum showed seven

    methyl protons ( 1.28, 1.18, 0.92, 1.12, 1.60, 1.14, 0.97 ppm; each 3H, s), one olefinic

  • Chemical and Pharmaceutical Bulletin Advance Publication

    methine proton ( 5.47, br s), and four sugar anomeric protons ( 4.82, d, J = 7.5 Hz; 5.38, d,

    J = 7.5 Hz; 5.85, d, J = 7.5 Hz; 6.37, d, J = 8.0 Hz). The signals of seven methyl carbons at

    28.2, 17.6, 16.7, 17.7, 24.9, 28.7 and 24.7 ppm, two olefinic methine carbons at 123.1 and

    144.3 ppm, four sugar carbons at 104.5, 104.6, 103.6 and 95.9 ppm, and two carbons at

    177.3 and 96.5 ppm linked to glycan part were also observed in the 13

    C-NMR spectrum. The

    above evidence revealed that 2 was a bisdesmosidic glycoside. And the aglycone part of this

    compound was determined as 2, 3, 19-trihydroxyolean-12-ene-28-oic acid comparing the

    1H and

    13C NMR signals of 2 with those of 3-O--D-glucopyranosyl-2, 3,

    19-trihydroxyolean-12-en-28-oic acid-28-O--D-glucopyranoside. 12) According to the 1H

    and 13

    C-NMR signals, the aglycone and sugar moieties of 2 were assigned based on the

    2D-NMR spectra, and the exact glycosidic linkages were unambiguously confirmed by the

    following HMBC correlations between H-1 ( 6.37) of a glucose and C-28 ( 177.3) of

    aglycone part; H-1 ( 4.82) of the inner glucose and C-3 ( 96.5) of aglycone part; H-1 (

    5.38) of the 3-O-glucose and C-3 ( 88.9) of inner glucose; H-1 ( 5.85) of the

    2-O-glucose and C-2 ( 78.3) of inner glucose. The -anomeric configurations of the glucose

    units were established by its 3JH1, H2 coupling constants (7.5-8.0 Hz). On the basis of above

    results compound 2, named as Catunaroside J, was determined as

    3-O--D-glucopyranosyl-(12)-[-D-glucopyranosyl-(13)]--D-glucopyranosyl-arjunic

    acid 28-O--D-glucopyranoside.

    Compound 3, also an amorphous powder, has the molecular formula of C48H78O20 as

    indicated from its HR-ESI-MS (m/z 997.5001 [M + Na]+) spectrum. Acid hydrolysis implied

  • Chemical and Pharmaceutical Bulletin Advance Publication

    that compound 3 only contained glucose by comparing Rf value with that of authentic sample.

    The 13

    C-NMR spectrum revealed 48 signals, of which 30 were assigned to the aglycone and

    18 to the sugars. The 1H-NMR spectrum exhibited signals for seven methyl protons ( 1.28 s,

    1.17 s, 0.88 s, 1.06 s, 1.70 s, 1.43 s and 1.12 d J= 6.5 Hz), one olefinic methine proton ( 5.56,

    br s) and three sugar anomeric protons ( 4.82, d, J = 7.5 Hz; 5.38, d, J = 7.5 Hz; 5.85, d, J =

    8.0 Hz). In the 13

    C-NMR spectrum, the signals of seven methyl carbons at 28.2, 17.8, 16.6,

    17.2, 24.7, 27.1 and 16.8 ppm, two olefinic methine carbons at 128.0 and 139.9 ppm, three

    sugar carbons at 104.4, 104.7 and 103.6 ppm were observed. The above evidence suggested

    that 3 may be an urs-12-ene type triterpenoid glycoside with three glucose residue. The NMR

    characteristic carbon signals ( 66.6, 72.8 ppm) and proton signal ( 1.12 d J= 6.5 Hz)

    suggested that the aglycone part was tormentic acid, then it was proved by comparing with

    NMR data from reference.14)

    The carbon signals in 13

    C-NMR spectrum at 96.4 (C-3) and

    180.6 (C-28) inferred compound 3 was a 3-O-monodesmosidic saponin. The -anomeric

    configurations of the glucose units were established according to its 3JH1, H2 coupling

    constants (7.5-8.0 Hz). The sequence of the glycan part connected to C-3 of the aglycone was

    deduced from the following HMBC correlations: H-1 ( 4.82) of inner glucose with C-3 (

    96.4) of aglycone part, H-1 ( 5.38) of 3-O-glucose with C-3 ( 88.9), and H-1 ( 5.85) of

    2-O-glucose with C-2 ( 78.3). From the above evidence, compound 3 was identified as

    3-O--D-glucopyranosyl-(12)-[-D-glucopyranosyl-(13)]--D-glucopyranosyl-tormentic

    acid, named as Catunaroside K.

  • Chemical and Pharmaceutical Bulletin Advance Publication

    Compound 4, obtained as an amorphous powder, was deduced to have the molecular

    formula C48H78O19 as indicated from HR-ESI-MS (m/z: 981.5080 [M + Na]+) data. The IR

    spectrum showed the presence of C=O group at 1741 cm-1

    and a C=C group at 1659 cm-1

    . The

    1H-NMR spectrum revealed signals due to seven methyl protons ( 1.25 s, 1.20 s, 0.80 s, 1.02

    s, 1.74 s, 1.45, s and 1.07 d, J = 7.0 Hz), an olefinic proton ( 5.59 br s) and three anomeric

    protons ( 4.84, d, J = 7.6 Hz; 5.38, d, J = 7.6 Hz; 5.73, d, J = 7.6 Hz). The corresponding

    signals at 28.0, 16.7, 15.5, 17.2, 24.7, 27.2 and 16.8 (seven methyl carbons) ppm, 128.0

    and 140.0 (an olefinic carbons) ppm, and 105.1, 104.7 and 103.8 (three anomeric carbons)

    ppm were also observed in 13

    C-NMR spectrum. Based on above observations, the NMR

    signals of 4 were in good agreement with those of sibiricasaponins B (pomolic acid

    3-O-(3-O-sulfo)--L-arabinopyranoside) 15) except for the signals of 3-O-substituted sugar

    moieties. Acid hydrolysis of 4 showed the only existence of glucose. The exact sugar

    arrangement was determined to be

    3-O--D-glucopyranosyl-(12)-[-D-glucopyranosyl-(13)]--D-glucose according to the

    reported NMR data of aralia saponin V. 16)

    The conclusion was then proved by the HMBC

    correlations between signals at 4.84 (H-1) of inner glucose and 96.4 (C-3) of aglycone

    part, 5.38 (H-1) of 3-O-glucose and 88.6 (C-3), and 5.73 (H-1) of 2-O-glucose and

    79.3 (C-2). Thus compound 4 was elucidated as

    3-O--D-glucopyranosyl-(12)-[-D-glucopyranosyl-(13)]--D-glucopyranosyl-pomolic

    acid, named as Catunaroside L.

  • Chemical and Pharmaceutical Bulletin Advance Publication

    Compound 5 and 6 were elucidated as Arjunetoside and RandiasaponinVII separately by

    comparison of their spectrum data with data reported in the literatures (IR, MS, 1H and

    13C-NMR).

    12, 17)

    Experimental

    General

    Silica gel (100-200 mesh and 200-300 mesh, Qingdao Haiyang Chemical Co., Ltd.),

    Macroporous resin D101, Lichroprep RP-18 (Merck) and Sephadex LH-20 (Pharmacia) were

    used for column chromatography. TLC was performed on precoated silica gel 60 F254 plates

    (Qingdao Haiyang Chemical Co., Ltd.), and detection was achieved by 10% H2SO4-EtOH.

    Semipreparative HPLC was carried out using an ODS column (YMC-Pack ODS-5-A, 250

    10 mm i.d., 5m; YMC) on a Waters-600 HPLC system equipped with a Waters-996

    photodiode array detector. IR spectra were measured with a Bruker EQUINOX55 infrared

    spectrometer. 1

    H and 13

    C-NMR spectra were recorded on a Bruker DRX-500 spectrometer

    (SiMe4 as internal standard). MS were obtained on MDS SCIEX API 2000 LC/MS/MS

    instrument for ESI and Bruker BioTOF Q spectrometer for HR-ESI. GC analysis were done

    on Agilent 1200 with HP-5 column (0.32 mm30 mm, 0.25 m) and 1200 FID detector.

    Plant Material

    The stem bark of C. spinosa, collected from Sanya, Hainan Province, P.R.China in

    February 2006, was identified by professor Si Zhang (South China Sea Institute of

    Oceanology, Chinese Academy of sciences). And a voucher specimen has been deposited in

  • Chemical and Pharmaceutical Bulletin Advance Publication

    the South China Sea Institute of Oceanology, Chinese Academy of Sciences (accession

    number: GKLMMM020).

    Extraction and Isolation

    The n-BuOH extract (170 g), obtained from air-dried and powered plant material using

    method reported previously9)

    , was passed through a macroporous resin (D101) column eluted

    with H2O and EtOH-H2O (30:70, 60:40, 95:5) in turn. The EtOH-H2O (60:40) eluted portion

    (35 g) from n-BuOH soluble fraction was subjected to silica gel CC eluted with

    CHCl3-MeOH (90:10-50:50) to give fractions a-f. Fraction b was separated by Sephadex

    LH-20 eluting with MeOH, then fractions 2-10 and 11-20 were purified by preparative HPLC

    eluting with MeOH-H2O (45:55) and MeOH-H2O (50:50) to obtain compounds 1 (15 mg), 5

    (12 mg) and 6 (12 mg) separately; Fraction f was rechromatographed to silica gel CC eluted

    with CHCl3-MeOH-H2O (80:20:5), then fraction 12 was purified by preparative HPLC using

    MeOH-H2O (48:52) to yield compound 2 (21 mg); The EtOH-H2O (95:5) eluted portion (10 g)

    was subjected to silica gel CC eluted with CHCl3-MeOH (98:2-50:50) to give fractions A-G.

    Fraction E was purified by sephadex LH-20 (MeOH), then separated by preparative HPLC to

    obtain compound 3 (19 mg) using MeOH-H2O (65:35) and compound 4 (10 mg) using

    MeOH-H2O (68:32).

    Catunaroside I (1)

    Colorless amorphous powder, []20D = + 12.7 (c = 0.5, MeOH). IR (KBr, cm1

    ) max: 3417,

    1726, 1643. 1H-NMR (500 MHz, pyridine-d5) and

    13C-NMR (125 MHz, pyridine-d5) data: see

  • Chemical and Pharmaceutical Bulletin Advance Publication

    table 1 and table 2. ESIMS m/z: 997 [M + Na]+, 1013 [M + K]

    +. HR-ESI-MS m/z: 997.4980

    [M + Na]+ (Calcd for C48H78O20Na, 997.4984).

    Catunaroside J (2)

    Colorless amorphous powder, []20D = + 39.1 (c = 0.3, MeOH). IR (KBr, cm1

    ) max: 3420,

    1735, 1640. 1H-NMR (500 MHz, pyridine-d5) and

    13C-NMR (125 MHz, pyridine-d5) data: see

    table 1 and table 2. ESI-MS m/z: 1159[M + Na]+. HR-ESI-MS m/z: 1159.5563 [M + Na]

    +

    (Calcd for C54H88O25Na, 1159.5512).

    Catunaroside K (3)

    Colorless amorphous powder, []20D = + 27.8 (c = 0.3, MeOH). IR (KBr, cm1

    ) max: 3419,

    1730, 1643. 1H-NMR (500 MHz, pyridine-d5) and

    13C-NMR (125 MHz, pyridine-d5) data: see

    table 1 and table 2. ESI-MS m/z: 997 [M + Na]+, 1013 [M + K]

    +. HR-ESI-MS m/z: 997.5001

    [M + Na]+ (Calcd for C48H78O20Na, 997.4984).

    Catunaroside L (4)

    Colorless amorphous powder, []20D = + 40.3 (c = 0.5, MeOH). IR (KBr, cm1

    ) max: 3422,

    1741, 1659. 1H-NMR (500 MHz, pyridine-d5) and

    13C-NMR (125 MHz, pyridine-d5) data: see

    table 1 and table 2. ESI-MS m/z: 981 [M + Na]+, 997 [M + K]

    +. HR-ESI-MS m/z: 981.5080

    [M + Na]+ (Calcd for C48H78O19Na, 981.5035).

    Acid Hydrolysis of 1-6 and determination of the absolute configuration of glucoses.

  • Chemical and Pharmaceutical Bulletin Advance Publication

    Acid hydrolysis of Compounds 1-6 was done using the method reported previously. 10)

    The

    sugars were identified by comparing of the Rf value with that of glucose on TLC plate eluted

    with CHCl3-MeOH-H2O (8:7:1) solvent system, visualized with ethanol-10% H2SO4 spraying

    and then heating. The sugar residue and the authentic samples of D-glucose and L-glucose

    were dissolved in 0.2 ml anhydrous pyridine and L-cysteine methyl ester hydrochloride, then

    warmed at 60oC for 1 h. The trimethylsilylation reagent trimethylsilylimidazole was added,

    followed by warming at 60oC for 1 h. After drying the residue was partition between H2O and

    cyclohexane. The cyclohexane layer was analyzed by GC using a HP-5 column. The

    temperatures of the injector and detector were 270 and 280 oC, respectively. A temperature

    gradient system used for the oven was started with 160 oC for 4 min and increased up to 240

    oC at a rate of 6

    oC/min. The retention time (24.15 min) of sugar residue were the same with

    that of D-glucose.

    Acknowledgments

    This work was financially supported by the Grant of the 12th Five-year Plan for University

    Key Academic Subject (Pharmacology), Zhejiang Province, CHINA, the Science and

    Technology Program of Jiaxing (2013AY21047) and the 2011 Annual Jiaxing Key Science

    and Technology Innovation Team.

    Conflict of Interest

    The authors declare no conflict of interest.

  • Chemical and Pharmaceutical Bulletin Advance Publication

    References

    (1) Hamerski L., Furlan M., Silva D. H. S., Cavalheiro A. J., Eberlin M. N., Tomazela D. M.,

    Bolzani V. D. S., phytochemistry, 63, 397-400 (2003).

    (2) Atal C. K., Lamba S. S., Indian J. Pharm., 22, 120-122 (1960).

    (3) Satpute K. L., Jadhav M. M., Karodi R. S., Katare Y. S., Patil M. J., Rub R., Bafna A. R.,

    J Pharmcogn. Phytother., 1, 36-40 (2009).

    (4) Dubois M. A., Benze S., Wagner H., Planta Med., 56, 451-454 (1990).

    (5) Sati S. P., Chaukiyal D. C. Sati O. P., Yamada F., Ono M., J. Nat. Prod., 52, 376-379

    (1989).

    (6) Sati O. P., Rana U., Chaukiyal D. C., Madhusudanan K. P., Bhakum D. S., Planta Med.,

    53, 530-531 (1987).

    (7) Sotheeswaran S., Bokel M., Kraus W., Phytochemistry, 28, 1544-1546 (1989).

    (8) Gao G. C., Qi S.H., Zhang S., Yin H., Xiao Z. H., Li M. Y., Li Q. X., Pharmazie, 63,

    542-544 (2008).

    (9) Gao G. C., Luo X. M., Wei X. Y., Qi S. H., Yin H., Xiao Z. H., Zhang S., Helv. Chim.

    Acta., 93, 339-344 (2010).

    (10) Gao G. C., Lu Z. X., Tao S. H., Zhang S., Wang F. Z., Li Q. X., Can. J. Chem., 89,

    1277-1282 (2011).

  • Chemical and Pharmaceutical Bulletin Advance Publication

    (11) Gao G. C., Lu Z. X., Tao S. H., Zhang S., Wang F. Z., Carbohydr. Res., 346,

    2200-2205 (2011).

    (12) Upadhyay R. K., Pandey M. B., Jha R. N., Singh V. P., Pandey V. B., J. Asian Nat.

    Prod. Res., 3, 207-212 (2001).

    (13) Zhang Q. Y., Zhao Y. Y., Wang B., Tu G. Z., Chem. Pharm. Bull., 51, 574-578 (2003).

    (14) Taniguchi S., Imayoshi Y., Kobayashi E., Takamatsu Y., Ito H., Hatano T., Sakagami

    H., Tokuda H., Nishino H., Sugita D., Shimura S., Yoshida T., Phytochemistry, 59

    315-323 (2002).

    (15) Song Y. L., Zeng K. W., Shi T. X., Jiang Y., Tu P. F., Fitoterapia, 84, 295-301 (2013).

    (16) Song S. J., Nakamura N., Ma C. M., Hattori M., Xu S. X., Phytochemistry, 56, 491-497

    (2001).

    (17) Sahpaz S., Gupta M. P., Hostettmann K., Phytochemistry, 54, 77-84 (2000).

  • Chemical and Pharmaceutical Bulletin Advance Publication

    Table 1. Selected 1H-NMR Spectroscopic Data of 1-4 in Pyridine-d5 (500, 125MHz )

    Table 2. 13

    C-NMR Spectroscopic Data of 1-4 in Pyridine-d5 (500, 125MHz )

    Fig. 1. Structures of Compounds 1-6

  • Chemical and Pharmaceutical Bulletin Advance Publication

    Table 1. Selected 1H-NMR Spectroscopic Data of 1-4 in Pyridine-d5 (500, 125MHz )

    Position 1 2 3 4

    2 4.00 3.94 3.93 2.04 m

    3 3.24 (d, 9.5) 3.14 (d, 9.0) 3.16 (d, 9.0) 3.28 (dd, 4.4, 11.5)

    12 5.49 (br s) 5.47 (br s) 5.54 (br s) 5.59 (br s)

    18 3.53 (br s) 3.51 (br s) 3.03 (br s) 3.05 (br s)

    19 3.57(br s) 3.55(br s)

    23 1.37 (s) 1.28 (s) 1.28 (s) 1.25 (s)

    24 1.05 (s) 1.18 (s) 1.17 (s) 1.20 (s)

    25 0.96 (s) 0.92 (s) 0.88 (s) 0.80 (s)

    26 1.14 (s) 1.12 (s) 1.06 (s) 1.02 (s)

    27 1.63 (s) 1.60 (s) 1.70 (s) 1.74 (s)

    29 1.14 (s) 1.14 (s) 1.43 (s) 1.45 (s)

    30 0.98 (s) 0.97 (s) 1.12 (d, 6.5) 1.07 (d, 7.0)

    3-O-

    1 4.91 (d, 8.0) 4.82 (d, 7.5) 4.82 (d, 7.5) 4.84 (d, 7.6)

    2 4.09 4.42 4.41 4.42

    3 4.23 4.26 4.27 4.25

    4 4.10 4.00 3.99 4.01

    5 4.22 3.93 3.92 3.92

    6 4.42, 4.53 4.31, 4.48 4.31, 4.49 4.30, 4.48

    3-O-

    1 5.29 (d, 7.5) 5.38 (d, 7.5) 5.38 (d, 7.5) 5.38 (d, 7.6)

    2 4.12 4.21 4.32 4.28

    3 4.30 4.22 4.23 4.25

    4 4.19 4.16 4.16 4.17

    5 4.25 4.28 4.31 4.30

    6 4.42, 4.53 4.43, 4.53 4.47, 4.54 4.42, 4.55

    2-O-

    1 5.85 (d, 7.5) 5.85 (d, 8.0) 5.73 (d, 7.6)

    2 4.06 4.06 4.04

    3 4.15 4.16 4.15

    4 3.93 3.92 3.98

    5 3.92 3.91 3.90

    6 4.18, 4.26 4.18, 4.26 4.17, 4.26

    28-O-

    1 6.38 (d, 8.0) 6.37 (d, 8.0)

    2 4.23 4.22

    3 4.04 4.05

    4 4.38 4.36

    5 4.37 4.30

    6 4.25,4.32 4.43, 4.53

    Overlapped proton signals are reported without designated multiplicity.

  • Chemical and Pharmaceutical Bulletin Advance Publication

    Table 2. 13C-NMR Spectroscopic Data of 1-4 in Pyridine-d5 (500, 125MHz )

    Position 1 2 3 4 Position 1 2 3 4

    1 47.0 47.1 47.4 38.8 3-O-

    2 66.6 66.6 66.6 26.4 1 106.0 104.5 104.4 105.1

    3 95.7 96.5 96.4 89.5 2 75.5 78.3 78.3 79.3

    4 40.7 41.0 40.3 39.6 3 88.8 88.9 88.9 88.6

    5 55.7 55.8 55.7 55.9 4 69.7 69.9 69.9 70.1

    6 18.7 18.8 18.7 18.6 5 78.1 78.0 78.0 77.7

    7 33.0 33.1 33.4 33.5 6 62.2 63.5 63.5 63.4

    8 40.2 40.2 40.9 40.3 3-O-

    9 48.2 48.3 47.7 47.7 1 105.9 104.6 104.7 104.7

    10 38.0 38.0 37.8 36.9 2 74.3 74.2 76.2 76.4

    11 24.2 24.2 24.0 24.0 3 78.7 78.7 78.7 78.6

    12 122.9 123.1 128.0 128.0 4 71.6 71.6 71.6 71.6

    13 144.3 144.3 139.9 140.0 5 78.3 78.8 78.8 78.6

    14 42.2 42.2 42.4 42.4 6 62.2 62.2 62.2 62.6

    15 29.0 29.0 29.3 29.3 2-O-

    16 28.0 28.0 26.4 26.4 1 103.6 103.6 103.8

    17 46.5 46.5 48.3 48.3 2 75.5 75.5 75.4

    18 44.6 44.6 54.6 54.6 3 78.6 78.6 78.6

    19 81.0 81.1 72.8 72.7 4 72.8 72.7 72.7

    20 35.5 35.6 42.1 42.1 5 77.9 77.9 77.8

    21 28.9 29.0 26.9 27.0 6 62.4 62.3 62.4

    22 33.1 33.2 38.5 38.5 28-O-

    23 28.4 28.2 28.2 28.0 1 95.9 95.9

    24 18.0 17.6 17.8 16.7 2 74.1 74.2

    25 16.6 16.7 16.6 15.5 3 78.9 79.0

    26 17.6 17.7 17.2 17.2 4 71.1 71.1

    27 24.9 24.9 24.7 24.7 5 79.3 79.3

    28 177.2 177.3 180.6 180.7 6 62.5 62.2

    29 28.7 28.7 27.1 27.2

    30 24.6 24.7 16.8 16.8

  • Chemical and Pharmaceutical Bulletin Advance Publication

    Fig. 1. Structures of Compounds 1-6